[{"Assets_0_Q3_USD":470896000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-158318000.0,"NetIncomeLoss_1_Q3_USD":-38346000.0,"NetIncomeLoss_3_Q3_USD":-129281000.0,"StockholdersEquity_0_Q3_USD":406808000.0,"Ticker":"HRTX","CIK":"818033","name":"HERON THERAPEUTICS, INC. \/DE\/","OfficialName":"Heron Therapeutics Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"558709361.0","Country":"United States","Sector":"Consumer Durables","Industry":"Specialty Chemicals","Market":"NASDAQ","SP500":"nan","filed":"20181107"}]